These 20 women are 2018's Fiercest in the life sciences industry.
Read 2018's Fiercest Women in Life Sciences report!
The FDA cleared Mariner Endosurgery's augmented reality surgical navigation system that provides an overlay similar to a heads-up display.
Roche teamed up with immuno-oncology competitor Merck to develop a pan-cancer diagnostic for its Keytruda therapy in mismatch repair deficiency.
The FDA cleared XenoTherapeutics to begin the first human clinical trial that uses live skin cells derived from pigs as a burn treatment.
Olympus pleaded guilty to not filing adverse event reports as required by the FDA for its duodenoscopes, agreeing to $85 million in fines and forfeiture.
The FDA cleared its first digital therapeutic for patients with opioid use disorder: an app by Pear Therapeutics to be used alongside medications.
A pilot clinical study demonstrated how Kaia Health’s artificial intelligence-based smartphone app could reduce a patient’s COPD symptoms.
10x Genomics is making moves into the emerging field of tissue genomics by buying Spatial Transcriptomics and its location-based mRNA analysis tools.
Luma Therapeutics launched its UV-based plaque psoriasis device, available through a dermatologist or Luma’s telehealth provider, HealthLens.
Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica.
The new Apple Watch’s electrocardiogram capability has gone live, available as a free software update that allows for wrist-based ECGs on the go.
